Dr. Allison Lipitz-Snyderman is a health services researcher focused on quality assessment and improvement in cancer care. Her research falls into three general areas: assessment of variation in practice and outcomes, examination of harm due to medical care, and evaluation of quality improvement activities. Dr. Lipitz-Snyderman received funding from the National Institute for Health Care Management Foundation to assess the extent of physician-driven variation in the use of services that tend to be overused. She is currently building on this work to examine hospital-level variation in outcomes of cancer care. Dr. Lipitz-Snyderman has worked to assess the burden of potentially preventable harm that occurs during cancer treatment in both inpatient and outpatient settings. She led a study to develop an oncology-specific ‘trigger tool’ to detect harm from medical records for patients with cancer over the care continuum, funded by the United Hospital Fund. Dr. Lipitz-Snyderman also led an evaluation of a multifaceted intervention, the Michigan Keystone ICU Project, aimed to reduce device-related bloodstream infections across the state of Michigan, along the outcomes of mortality and length of stay using population-based data. Dr. Lipitz-Snyderman is a member of the MSK Center for Health Policy and Outcomes and is Co-chair of the MSK Cancer Alliance Quality, Value, and Outcomes Committee.
